These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 38940026)
1. Dissecting Crucial Gene Markers Involved in HPV-Associated Oropharyngeal Squamous Cell Carcinoma from RNA-Sequencing Data through Explainable Artificial Intelligence. Sekaran K; Varghese RP; Krishnan S; Zayed H; El Allali A; Doss GPC Front Biosci (Landmark Ed); 2024 Jun; 29(6):220. PubMed ID: 38940026 [TBL] [Abstract][Full Text] [Related]
2. Discovery and development of differentially methylated regions in human papillomavirus-related oropharyngeal squamous cell carcinoma. Ren S; Gaykalova D; Wang J; Guo T; Danilova L; Favorov A; Fertig E; Bishop J; Khan Z; Flam E; Wysocki PT; DeJong P; Ando M; Liu C; Sakai A; Fukusumi T; Haft S; Sadat S; Califano JA Int J Cancer; 2018 Nov; 143(10):2425-2436. PubMed ID: 30070359 [TBL] [Abstract][Full Text] [Related]
3. Mutation patterns in recurrent and/or metastatic oropharyngeal squamous cell carcinomas in relation to human papillomavirus status. Reder H; Wagner S; Wuerdemann N; Langer C; Sandmann S; Braeuninger A; Dugas M; Gattenloehner S; Wittekindt C; Klussmann JP Cancer Med; 2021 Feb; 10(4):1347-1356. PubMed ID: 33527763 [TBL] [Abstract][Full Text] [Related]
4. Differential molecular characterization of human papillomavirus-associated oropharyngeal squamous cell carcinoma and its prognostic value. Wang H; Zhang Q; Zheng Z; Xin Y; Jiang X J Cell Mol Med; 2024 Oct; 28(19):e70073. PubMed ID: 39397259 [TBL] [Abstract][Full Text] [Related]
5. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma. Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438 [TBL] [Abstract][Full Text] [Related]
6. Stratification of HPV-associated and HPV-negative oropharyngeal squamous cell carcinomas based on DNA methylation epigenotypes. Nakagawa T; Matsusaka K; Misawa K; Ota S; Fukuyo M; Rahmutulla B; Kunii N; Sakurai D; Hanazawa T; Matsubara H; Okamoto Y; Kaneda A Int J Cancer; 2020 May; 146(9):2460-2474. PubMed ID: 31997344 [TBL] [Abstract][Full Text] [Related]
7. Mutation of chromatin regulators and focal hotspot alterations characterize human papillomavirus-positive oropharyngeal squamous cell carcinoma. Haft S; Ren S; Xu G; Mark A; Fisch K; Guo TW; Khan Z; Pang J; Ando M; Liu C; Sakai A; Fukusumi T; Califano JA Cancer; 2019 Jul; 125(14):2423-2434. PubMed ID: 30933315 [TBL] [Abstract][Full Text] [Related]
8. A Novel Functional Splice Variant of Guo T; Sakai A; Afsari B; Considine M; Danilova L; Favorov AV; Yegnasubramanian S; Kelley DZ; Flam E; Ha PK; Khan Z; Wheelan SJ; Gutkind JS; Fertig EJ; Gaykalova DA; Califano J Cancer Res; 2017 Oct; 77(19):5248-5258. PubMed ID: 28733453 [TBL] [Abstract][Full Text] [Related]
9. Explainable prediction model for the human papillomavirus status in patients with oropharyngeal squamous cell carcinoma using CNN on CT images. Fanizzi A; Comes MC; Bove S; Cavalera E; de Franco P; Di Rito A; Errico A; Lioce M; Pati F; Portaluri M; Saponaro C; Scognamillo G; Troiano I; Troiano M; Zito FA; Massafra R Sci Rep; 2024 Jun; 14(1):14276. PubMed ID: 38902523 [TBL] [Abstract][Full Text] [Related]
10. Raptor and rictor expression in patients with human papillomavirus-related oropharyngeal squamous cell carcinoma. Kondo S; Hirakawa H; Ikegami T; Uehara T; Agena S; Uezato J; Kinjyo H; Kise N; Yamashita Y; Tanaka K; Hasegawa N; Kiyuna A; Maeda H; Suzuki M; Gahana A BMC Cancer; 2021 Jan; 21(1):87. PubMed ID: 33482765 [TBL] [Abstract][Full Text] [Related]
11. Identification of a human papillomavirus-associated oncogenic miRNA panel in human oropharyngeal squamous cell carcinoma validated by bioinformatics analysis of the Cancer Genome Atlas. Miller DL; Davis JW; Taylor KH; Johnson J; Shi Z; Williams R; Atasoy U; Lewis JS; Stack MS Am J Pathol; 2015 Mar; 185(3):679-92. PubMed ID: 25572154 [TBL] [Abstract][Full Text] [Related]
12. AKR1C3 is a biomarker and druggable target for oropharyngeal tumors. Peraldo-Neia C; Ostano P; Mello-Grand M; Guana F; Gregnanin I; Boschi D; Oliaro-Bosso S; Pippione AC; Carenzo A; De Cecco L; Cavalieri S; Micali A; Perrone F; Averono G; Bagnasacco P; Dosdegani R; Masini L; Krengli M; Aluffi-Valletti P; Valente G; Chiorino G Cell Oncol (Dordr); 2021 Apr; 44(2):357-372. PubMed ID: 33211282 [TBL] [Abstract][Full Text] [Related]
13. Multiparametric MRI-based radiomics model for predicting human papillomavirus status in oropharyngeal squamous cell carcinoma: optimization using oversampling and machine learning techniques. Sim Y; Kim M; Kim J; Lee SK; Han K; Sohn B Eur Radiol; 2024 May; 34(5):3102-3112. PubMed ID: 37848774 [TBL] [Abstract][Full Text] [Related]
14. A novel prediction model for human papillomavirus-associated oropharyngeal squamous cell carcinoma using p16 and subcellular β-catenin expression. Qian G; Hu Z; Xu H; Müller S; Wang D; Zhang H; Kim S; Chen Z; Saba NF; Shin DM; Wang AY; Chen ZG J Oral Pathol Med; 2016 Jul; 45(6):399-408. PubMed ID: 26493274 [TBL] [Abstract][Full Text] [Related]
15. Identification of prognostic molecular biomarkers in 157 HPV-positive and HPV-negative squamous cell carcinomas of the oropharynx. Dogan S; Xu B; Middha S; Vanderbilt CM; Bowman AS; Migliacci J; Morris LGT; Seshan VE; Ganly I Int J Cancer; 2019 Dec; 145(11):3152-3162. PubMed ID: 31093971 [TBL] [Abstract][Full Text] [Related]
16. Human Papillomavirus Drives Tumor Development Throughout the Head and Neck: Improved Prognosis Is Associated With an Immune Response Largely Restricted to the Oropharynx. Chakravarthy A; Henderson S; Thirdborough SM; Ottensmeier CH; Su X; Lechner M; Feber A; Thomas GJ; Fenton TR J Clin Oncol; 2016 Dec; 34(34):4132-4141. PubMed ID: 27863190 [TBL] [Abstract][Full Text] [Related]
17. Elevated TLR5 expression in vivo and loss of NF-κΒ activation via TLR5 in vitro detected in HPV-negative oropharyngeal squamous cell carcinoma. Kylmä AK; Tolvanen TA; Carpén T; Haglund C; Mäkitie A; Mattila PS; Grenman R; Jouhi L; Sorsa T; Lehtonen S; Hagström J Exp Mol Pathol; 2020 Jun; 114():104435. PubMed ID: 32240617 [TBL] [Abstract][Full Text] [Related]
18. Assessing the capacity of methylated DNA markers of cervical squamous cell carcinoma to discriminate oropharyngeal squamous cell carcinoma in human papillomavirus mediated disease. Bartemes KR; Gochanour BR; Routman DM; Ma DJ; Doering KA; Burger KN; Foote PH; Taylor WR; Mahoney DW; Berger CK; Cao X; Then SS; Haller TJ; Larish AM; Moore EJ; Garcia JJ; Graham RP; Bakkum-Gamez JN; Kisiel JB; Van Abel KM Oral Oncol; 2023 Nov; 146():106568. PubMed ID: 37717549 [TBL] [Abstract][Full Text] [Related]
19. Predicting the radiosensitivity of HPV-negative oropharyngeal squamous cell carcinoma using miR-130b. Inoue H; Hirasaki M; Kogashiwa Y; Kuba K; Ebihara Y; Nakahira M; Sakai A; Okuda A; Sugasawa M Acta Otolaryngol; 2021 Jun; 141(6):640-645. PubMed ID: 33794725 [TBL] [Abstract][Full Text] [Related]
20. Oral health and human papillomavirus-associated head and neck squamous cell carcinoma. Mazul AL; Taylor JM; Divaris K; Weissler MC; Brennan P; Anantharaman D; Abedi-Ardekani B; Olshan AF; Zevallos JP Cancer; 2017 Jan; 123(1):71-80. PubMed ID: 27571516 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]